KIR2DS5 in the presence of HLA-C C2 protects against endometriosis

Immunogenetics

Volumn 67, Issue 4, 2015, Pages 203-209

  Nowak, Izabela ^a   Płoski, Rafał ^b   Barcz, Ewa ^b   Dziunycz, Piotr ^b   Kamiński, Paweł ^b   Kostrzewa, Grażyna ^b   Milewski, Łukasz ^b   Roszkowski, Piotr I ^b   Senitzer, David ^c   Malejczyk, Jacek ^b   Kuśnierczyk, Piotr ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Endometriosis; Human leukocyte antigen; Killer cell immunoglobulin like receptor; Linkage disequilibrium

Indexed keywords

HLA B ANTIGEN; HLA C ANTIGEN; HLA C C2 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG; HLA-C*02 ANTIGEN; KIR2DS4 PROTEIN, HUMAN; KIR2DS5 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; POLAND; PRIORITY JOURNAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; NATURAL KILLER CELL; YOUNG ADULT;

ADULT; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLAND; RECEPTORS, KIR; YOUNG ADULT;

EID: 84925507219     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-015-0828-3     Document Type: Article

References (43)

1. Abdallah JM, Goffinet B, Cierco-Ayrolles C, Perez-Enciso M (2003) Linkage disequilibrium fine mapping of quantitative trait loci: a simulation study. Genet Sel Evol 35:513–532
2. American Fertility Society (1985) Revised American Fertility Society classification of endometriosis. Fertil Steril 43:351–352
3. Berkkanoglu M, Arici A (2003) Immunology and endometriosis. Am J Reprod Immunol 50:48–59
4. Bhasi K, Zhang L, Brazeau D, Zhang A, Ramanathan M (2006) Information-theoretic identification of predictive SNPs and supervised visualization of genome-wide association studies. Nucleic Acids Res 34:e101
5. Burney RO, Giudice LC (2012) Pathogenesis and pathophysiology of endometriosis. Fertil Steril 98:511–519
6. Czaja K, Borer AS, Schmied L, Terszowski G, Stern M, Gonzalez A (2014) A comprehensive analysis of the binding of anti-KIR antibodies to activating KIRs. Genes Immun 15:33–37
7. Della Chiesa M, Romeo E, Falco M, Balsamo M, Augugliaro R, Moretta L (2008) Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. Eur J Immunol 38:2284–2289
8. Dmowski WP, Braun DP (2004) Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 18:245–263
9. Dunselman GAJ, Vermeulen N, Becker C et al (2014) ESHRE guideline: management of women with endometriosis. Hum Reprod 29:400–412
10. Excoffier L, Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921–927
11. Falco M, Moretta L, Moretta A, Bottino C (2013) KIR and KIR ligand polymorphism: a new area for clinical applications? Tissue Antigens 82:363–373
12. Frohn C, Schlenke P, Ebel B, Dannenberg C, Bein G, Kitchner H (1998) DNA typing for natural killer cell inhibiting HLA-Cw groups NK1 and NK2 by PCR-SSP. J Immunol Methods 218:155–160
13. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR (2015) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 43(Database issue):D784–D788
14. Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM (2009) KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med 206:2557–2572
15. Gupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, Agarwal A (2008) Pathogenic mechanisms in endometriosis-associated infertility. Fertil Steril 90:247–257
16. Hiby SE, Walker JJ, O’Shaughnessy KM, Redman CW, Carrington M, Trowsdale J (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200:957–965
17. Hou L, Chen M, Jiang B, Kariyawasam K, Ng J, Hurley CK (2009) In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans. Hum Immunol 70:733–737
18. Jiang J, Johnson C, Jayaraman J, Simecek N, Noble J, Moffatt MF (2012) Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res 22:1845–1854
19. Kitawaki J, Xu B, Ishihara H, Fukui M, Hasegawa G, Nakamura N (2007) Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis. Am J Reprod Immunol 58:481–486
20. Kulkarni S, Martin MP, Carrington M (2008) The Yin and Yang of HLA and KIR in human disease. Semin Immunol 20:343–352
21. Leung W, Iyengar R, Triplett B, Turner V, Behm FG, Holladay MS (2005) Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 174:6540–6545
22. Liu Z, Lin S (2005) Multilocus LD measure and tagging SNP selection with generalized mutual information. Genet Epidemiol 29:353–364
23. Maeda N, Izumiya C, Yamamoto Y, Oguri H, Kusume T, Fukaya T (2002) Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertil Steril 77:297–302
24. Matarese G, De Placido G, Nikas Y, Alviggi C (2003) Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease? Trends Mol Med 9:223–228
25. Middleton D, Gonzelez F (2010) The extensive polymorphism of KIR genes. Immunology 129:8–19
26. Montgomery GW, Nyholt DR, Zhao ZZ, Treloar SA, Painter JN, Missmer SA (2008) The search for genes contributing to endometriosis risk. Hum Reprod Update 14:447–457
27. Nakimuli A, Chazara O, Hiby SE et al (2015) A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia. PNAS 112:845–850
28. Niepiekło-Miniewska W, Majorczyk E, Matusiak Ł et al (2013) Protective effect of the KIR2DS1 gene in atopic dermatitis. Gene 527:594–600
29. Nowak I, Malinowski A, Tchórzewski H et al (2009) Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion. J Appl Genet 50:391–398
30. Nowak I, Majorczyk E, Wiśniewski A et al (2010) Does the KIR2DS5 gene protect from some human diseases? PLoS One 5:e12381
31. Nowak I, Magott-Procelewska M, Kowal A et al (2012) Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation. PLoS One 7:e44718
32. Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR (1991) Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 56:45–51
33. Oosterlynck DJ, Meuleman C, Waer M, Koninckx PR (1992) The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 58:290–295
34. Parham P (2005) MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5:201–214
35. Parham P, Norman PJ, Abi-Rached L, Guethlein LA (2012) Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci 19(367):800–811
36. Sampson J (1927) Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:422–467
37. Steiner NK, Dakshanamurthy S, Nguyen N, Hurley CK (2014) Allelic variation of killer cell immunoglobulin-like receptor 2DS5 impacts glycosylation altering cell surface expression levels. Hum Immunol 75:124–128
38. Sun JY, Gaidulis L, Miller MM, Goto RM, Rodriguez R, Forman SJ, Senitzer D (2004) Development of a multiplex PCR-SSP method for killer cell immunoglobulin-like receptor genotyping. Tissue Antigens 64:462–468
39. Tariverdian N, Theoharides TC, Siedentopf F, Gutiérrez G, Jeschke U, Rabinovich GA (2007) Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin Immunopathol 29:193–210
40. The Practice Committee of the American Society for Reproductive Medicine (2012) Endometriosis and infertility: a committee opinion. Fertil Steril 98:591–598
41. Ulukus M, Cakmak H, Arici A (2006) The role of endometrium in endometriosis. J Soc Gynecol Investig 13:467–476
42. Van der Meer A, Schaap NPM, Schattenberg A, van Cranenbroek B, Tijssen HJ, Joosten I (2008) KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients. Mol Immunol 45:3631–3638
43. Zhang C, Maeda N, Izumiya C, Yamamoto Y, Kusume T, Oguri H (2006) Killer immunoglobulin-like receptor and human leukocyte antigen expression as immunodiagnostic parameters for pelvic endometriosis. Am J Reprod Immunol 55:106–114